Ticker
NBYCompany Name
NOVABAY PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Total Assets | Inventory | Inventory to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 6.91M | $ 467K | 6.76% |
3/31/2025 | $ 9.87M | $ 0 | 0% |
12/31/2024 | $ 3.42M | $ 765K | 22.35% |
9/30/2024 | $ 3.88M | $ 473K | 12.2% |
6/30/2024 | $ 3.92M | $ 700K | 17.83% |
3/31/2024 | $ 5.36M | $ 663K | 12.38% |
12/31/2023 | $ 9.03M | $ 2.88M | 31.85% |
9/30/2023 | $ 12.85M | $ 3.49M | 27.18% |
6/30/2023 | $ 16.01M | $ 3.66M | 22.86% |
3/31/2023 | $ 14.82M | $ 3.8M | 25.61% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for NOVABAY PHARMACEUTICALS INC is calculated as follows: Inventory [ $ 785K ] / Assets [ $ 17.08M ]
(=) Inv. to Assets [ 4.6% ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 4.46K |
---|---|
min | 0% |
max | 98.39% |
average | 6.08% |
median | 0% |
std | 11.1% |